TheJobsMapOrano Med jobs and careers
Plano, TX, United States
About Orano Med
Based on an R&D program started in 2005, Orano Med has developed new processes for producing high-purity lead-212 (Pb-212), a rare radioactive isotope. Lead-212 is currently at the heart of promising projects in nuclear medicine to develop new treatments against cancer. The innovative approach, known as targeted alpha therapy (TAT), recognizes and destroys cancer cells while limiting the impact on nearby healthy cells. Macrocyclics, Inc., an Orano Med company, is the global leader in high performance chelating agent technology, offering a broad range of services and products. For more information please visit www.macrocyclics.com.
Founded in 2009 by Julien Dodet.
- Founded
- 2009
- Employees
- 125
- Headquarters
- Plano
Leadership
The top of Orano Med's org chart, with how many people report into each leader.
Nicolas Bozovic
Director Of Pharmaceutical Operations And Projects
32 reports
Thomas Priem
Responsable D Installations
5 reports
Pascal Mirocha
Chief Financial Officer Directeur Administratif ET Financier
3 reports
Maria Russo
Scientist
Bruno Chapelière
Pharmacien Responsable / Directeur Qualité
15 reports
Tania Stallons
Director, CMC
5 reports
Grant Swarm
Associate Director, Supply Chain
3 reports
Dr Evelyne Poli
Responsable De Production Pharmaceutique
2 reports
Roberto Rivera
Senior Operator
Hérico Tsaralaza
Supply Operations And Projects Engineer
Amy Wong Ph.D., Chemistry
Peptide Chemist ► Pursuing Peptide Drug Discovery Development For Nuclear Medicine Applications
Julien B.
Responsable Service Technique
1 report
Jobs at Orano Med
No open positions right now. Explore more companies on TheJobsMap.